Italian Medicines Agency

EMA starts rolling review of COVID-19 Vaccine (Vero Cell) Inactivated

EMA starts evaluating use of COVID-19 vaccine Comirnaty in young people aged 12 to 15

COVID-19 Vaccine Janssen: link between the vaccine and the occurrence of thrombosis in combination with thrombocytopenia

AstraZeneca’s COVID-19 vaccine: benefits and risks in context

Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from BioNTech/Pfizer and Moderna

COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets

COVID-19 Vaccine Janssen: assessment of very rare cases of unusual blood clots with low platelets continues

Third AIFA Report on COVID-19 Vaccine Surveillance

AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets

VAXZEVRIA/COVID-19 Vaccine AstraZeneca: link between the vaccine and the occurrence of thrombosis in combination with thrombocytopenia